Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Alirocumab and cardiovascular outcomes after acute coronary syndrome
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Alirocumab and cardiovascular outcomes after acute coronary syndrome'. Together they form a unique fingerprint.
Cardiovascular Outcomes
Keyphrases
100%
Acute Coronary Syndrome
Keyphrases
100%
Alirocumab
Keyphrases
100%
Placebo
Pharmacology, Toxicology and Pharmaceutical Science
66%
Placebo Groups
Keyphrases
33%
Low-density Lipoprotein Cholesterol Level
Keyphrases
33%
Statin (Protein)
Pharmacology, Toxicology and Pharmaceutical Science
33%
Low Density Lipoprotein Cholesterol
Pharmacology, Toxicology and Pharmaceutical Science
33%
Cite this